Selling or acquiring an independent pharmacy requires a broker who understands PBM reimbursements, DEA transfers, prescription file value, and SBA financing — not just general M&A.
Find Pharmacy Deals Without a BrokerIndependent pharmacy transactions are among the most technically complex deals in the lower middle market. A qualified broker must understand how to value prescription files, navigate DEA change-of-ownership requirements, assess DIR fee exposure, and structure deals that satisfy both SBA lenders and state pharmacy boards. The right broker accelerates your timeline and protects your valuation.
Boutique advisors focused exclusively on pharmacy and healthcare services transactions, with deep knowledge of PBM contracts, prescription file transfers, and regulatory approvals.
Best for: Sellers of compounding, specialty, or long-term care pharmacies seeking maximum valuation and a qualified buyer pool.
Generalist brokers with a dedicated healthcare practice covering pharmacies, medical practices, and ancillary services. Understand licensing and compliance but may lack PBM contract depth.
Best for: Independent retail pharmacies with $1M–$3M in revenue seeking buyers using SBA financing.
Brokers experienced structuring pharmacy deals through SBA 7(a) loans, including seller carry arrangements and inventory pricing to meet lender requirements.
Best for: Buyers seeking first-time pharmacy ownership using SBA financing with limited upfront capital.
Skip the broker — find deals direct
DealFlow OS surfaces off-market Pharmacy targets with seller signals and outreach angles. No commission.
How many independent pharmacy transactions have you closed in the last three years, and what was the average deal size?
Pharmacy deals require specialized knowledge of DEA transfers, PBM contracts, and prescription file valuation. Generic business broker experience is insufficient.
How do you value a pharmacy's prescription file, and do you account for DIR fee exposure and payer mix when calculating EBITDA?
Prescription file value and DIR fee liability are the two most misunderstood drivers of pharmacy valuation. A weak answer signals inexperience.
How do you vet buyers for pharmacist licensure, SBA eligibility, and ability to obtain DEA registration before accepting an offer?
Unqualified buyers waste months and expose sellers to confidentiality risk. Pre-qualification is essential in a licensed, regulated industry.
What is your process for managing DEA change-of-ownership and state board transfer requirements during the transaction?
Regulatory missteps during ownership transfer can delay closing by months or trigger DEA scrutiny that kills the deal entirely.
A pharmacy-specialized broker is strongly recommended. DEA transfers, PBM contract reviews, prescription file valuation, and state board approvals require expertise that general brokers rarely possess.
Pharmacies are typically valued at 3–5.5x EBITDA, with prescription file value, active patient count, refill rates, payer mix, and specialty service revenue all influencing the final multiple.
Most independent pharmacy sales take 12–24 months from preparation through closing, with DEA registration transfer and state board approval often driving the longest delays post-offer.
Yes, but your buyer must hold a pharmacist license or partner with one. SBA lenders and state boards require a licensed pharmacist responsible for pharmacy operations post-close.
More Pharmacy Guides
Find Brokers in Other Industries
DealFlow OS surfaces off-market targets, scores seller motivation, and writes your outreach. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers